FI863652A - 7-isopropoxiisflavoninklusionskomplex bildat med cyklodextrin och ett foerfarande foer dess framstaellning. - Google Patents

7-isopropoxiisflavoninklusionskomplex bildat med cyklodextrin och ett foerfarande foer dess framstaellning. Download PDF

Info

Publication number
FI863652A
FI863652A FI863652A FI863652A FI863652A FI 863652 A FI863652 A FI 863652A FI 863652 A FI863652 A FI 863652A FI 863652 A FI863652 A FI 863652A FI 863652 A FI863652 A FI 863652A
Authority
FI
Finland
Prior art keywords
isopropoxiisflavoninklusionskomplex
cyklodextrin
bildat
med
foerfarande foer
Prior art date
Application number
FI863652A
Other languages
English (en)
Other versions
FI86958C (fi
FI863652A0 (fi
FI86958B (fi
Inventor
Nee Szoeke Agnes Stadler
Jozsef Szejtli
Viktor Weiszfeiler
Zoltan Vargay
Katalin Kaloy
Vera Gergely
Tamas Szuets
Original Assignee
Chinoin Gyogyszer Es Vegyeszet
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chinoin Gyogyszer Es Vegyeszet filed Critical Chinoin Gyogyszer Es Vegyeszet
Publication of FI863652A0 publication Critical patent/FI863652A0/fi
Publication of FI863652A publication Critical patent/FI863652A/fi
Application granted granted Critical
Publication of FI86958B publication Critical patent/FI86958B/fi
Publication of FI86958C publication Critical patent/FI86958C/fi

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365Lactones
    • A61K31/366Lactones having six-membered rings, e.g. delta-lactones
    • A61K31/37Coumarins, e.g. psoralen
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B82NANOTECHNOLOGY
    • B82YSPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6949Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
    • A61K47/6951Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/08Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08BPOLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0006Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
    • C08B37/0009Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid alpha-D-Glucans, e.g. polydextrose, alternan, glycogen; (alpha-1,4)(alpha-1,6)-D-Glucans; (alpha-1,3)(alpha-1,4)-D-Glucans, e.g. isolichenan or nigeran; (alpha-1,4)-D-Glucans; (alpha-1,3)-D-Glucans, e.g. pseudonigeran; Derivatives thereof
    • C08B37/0012Cyclodextrin [CD], e.g. cycle with 6 units (alpha), with 7 units (beta) and with 8 units (gamma), large-ring cyclodextrin or cycloamylose with 9 units or more; Derivatives thereof
    • C08B37/0015Inclusion compounds, i.e. host-guest compounds, e.g. polyrotaxanes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nanotechnology (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Biotechnology (AREA)
  • Medical Informatics (AREA)
  • Biochemistry (AREA)
  • Materials Engineering (AREA)
  • Polymers & Plastics (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Biophysics (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Absorbent Articles And Supports Therefor (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pyrane Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
FI863652A 1985-09-10 1986-09-10 Foerfarande foer framstaellning av ett inklusionskomplex av 7-isopropoxi-isoflavon och cyklodextrin FI86958C (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
HU341585 1985-09-10
HU853415A HU199444B (en) 1985-09-10 1985-09-10 Process for producing 7-isopropoxy-isoflavone-cyclodextrene inclusion complex and pharmaceutical compositions therefrom

Publications (4)

Publication Number Publication Date
FI863652A0 FI863652A0 (fi) 1986-09-10
FI863652A true FI863652A (fi) 1987-03-11
FI86958B FI86958B (fi) 1992-07-31
FI86958C FI86958C (fi) 1992-11-10

Family

ID=10963942

Family Applications (1)

Application Number Title Priority Date Filing Date
FI863652A FI86958C (fi) 1985-09-10 1986-09-10 Foerfarande foer framstaellning av ett inklusionskomplex av 7-isopropoxi-isoflavon och cyklodextrin

Country Status (16)

Country Link
US (2) US4826963A (fi)
EP (1) EP0214647B1 (fi)
JP (1) JPH0688993B2 (fi)
KR (1) KR900000542B1 (fi)
CN (1) CN1006889B (fi)
AT (1) ATE87319T1 (fi)
CA (1) CA1288424C (fi)
CS (1) CS276944B6 (fi)
DD (1) DD254939A5 (fi)
DE (1) DE3688114D1 (fi)
FI (1) FI86958C (fi)
HU (1) HU199444B (fi)
PL (1) PL261349A1 (fi)
RU (1) RU2022970C1 (fi)
SU (1) SU1757472A3 (fi)
UA (1) UA19813A (fi)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5221695A (en) * 1987-12-22 1993-06-22 Glaxo Group Limited Aqueous formulation containing a piperidinylcyclopentylheptenoic acid derivative and beta-cyclodextrin
YU45837B (sh) * 1988-01-18 1992-07-20 LEK TOVARNA FARMACEVTSKIH IN KEMIČKIH IZDELKOV d.d. Postopek za pripravo novega inkluzijskega kompleksa nikardipina oz. njegovega hidroklorida z beta-ciklodekstrinom
DE3809808A1 (de) * 1988-03-23 1989-10-05 Hexal Pharma Gmbh & Co Kg Feste, insbesondere festorale und rektale, etofenamat enthaltende arzneimittel
MY106598A (en) * 1988-08-31 1995-06-30 Australian Commercial Res & Development Ltd Compositions and methods for drug delivery and chromatography.
JPH02142709A (ja) * 1988-11-24 1990-05-31 Kurita Water Ind Ltd 有害生物防除剤
WO1991004026A1 (en) * 1989-09-14 1991-04-04 Australian Commercial Research & Development Limited Drug delivery compositions
IT1241673B (it) * 1989-10-09 1994-01-27 Istituto Biochimico Italiano Complessi di inclusione di silibinina con ciclodestrina, loro preparazione e composizioni farmaceutiche che li contengono.
WO1991013100A1 (en) * 1990-03-02 1991-09-05 Australian Commercial Research & Development Limited Cyclodextrin compositions and methods for pharmaceutical and industrial applications
IT1241079B (it) * 1990-03-23 1993-12-29 Chiesi Farma Spa Composizioni farmaceutiche contenenti ipriflavone,procedimento per la loro preparazione e relativo impiego terapeutico
US5221735A (en) * 1991-02-25 1993-06-22 Hoffmann-La Roche Inc. Cyclodextrin-polyene inclusion complexes
JPH06248193A (ja) * 1993-02-25 1994-09-06 Ensuiko Sugar Refining Co Ltd クロセチン含有着色料
HU212932B (en) * 1993-08-02 1996-12-30 Chinoin Gyogyszer Es Vegyeszet Parmaceutical composition containing ipriflavone, hydroxyapatit and tricalciumphosphate for treating lack of bones and process for producing the composition
CZ306394A3 (en) * 1993-12-14 1995-08-16 Lilly Co Eli Aqueous solution of inclusion complex of benzothiophene derivative with water-soluble cyclodextrins, process of its preparation and a pharmaceutical composition containing thereof
US5506211A (en) * 1994-05-09 1996-04-09 The Uab Research Foundation Genistein for use in inhibiting osteroclasts
US6298558B1 (en) * 1994-10-31 2001-10-09 The Gillette Company Skin engaging member
HUT73844A (en) * 1994-11-11 1996-09-30 Chinoin Gyogyszer Es Vegyeszet New taxol complexes and pharmaceutical compositions containing them
WO1996040262A2 (en) * 1995-06-07 1996-12-19 The Procter & Gamble Company Process for preparing encapsulated water soluble beta-carotene
US5847108A (en) * 1996-03-21 1998-12-08 Fujicco Co., Ltd. Clathrate of isoflavone derivatives and edible composition comprising the same
WO1999044621A1 (fr) * 1998-03-06 1999-09-10 Meiji Seika Kaisha, Ltd. Agents pour prevenir/traiter l'osteoporose
JP4006133B2 (ja) 1999-05-17 2007-11-14 松谷化学工業株式会社 可溶性イソフラボン組成物及びその製造方法
US7182972B2 (en) * 1999-12-17 2007-02-27 Quercegen Pharma, Llc Water-soluble bean-based extracts
US6541062B2 (en) 1999-12-17 2003-04-01 Mitsunori Ono Water-soluble soybean extracts
AU783822B2 (en) 1999-12-17 2005-12-08 Lan Bo Chen Water-soluble bean-based extracts
JP4585074B2 (ja) * 2000-03-28 2010-11-24 ライオン株式会社 薬剤組成物の製造方法
CA2304906A1 (en) * 2000-04-07 2001-10-07 1411198 Ontario Limited 13-hode, a regulator of vascular biocompatibility and an inhibitor of cell hyperplasia
DE10211192A1 (de) * 2002-03-14 2003-09-25 Beiersdorf Ag Isoflavanoide gegen Hautalterung und Akne
US6855359B2 (en) * 2002-11-15 2005-02-15 Cargill, Incorporated Soluble isoflavone compositions
US7157446B2 (en) * 2003-05-02 2007-01-02 Bristol Myers Squibb Company Complex of ras-farnesyltransferase inhibitor, a cyclodextrin, and ethanol
US6960300B2 (en) * 2003-09-08 2005-11-01 Sami Labs Limited Process for preparing water soluble diterpenes and their applications
KR100847225B1 (ko) 2003-10-24 2008-07-17 (주)아모레퍼시픽 사이클로 덱스트린의 분자 인식 기능을 이용한이소플라본의 추출방법
MX2009003128A (es) * 2006-11-03 2009-04-06 Corn Products Int Inc Extractos de soya encapsulados y procesos para prepararlos.
JP4978209B2 (ja) * 2007-01-22 2012-07-18 株式会社イヅツみそ フリーズドライ味噌の製造方法
KR100929920B1 (ko) * 2007-09-05 2009-12-04 주식회사 마크로케어 사이클로덱스트린 및 이의 유도체에 소수성 생리활성성분이 포접된 포접체의 제조방법 및 이로써 제조된포접체의 용도
EP2106786A1 (de) * 2008-04-04 2009-10-07 Roewer, Norbert, Univ.-Prof. Dr. med. Pharmazeutische Zubereitung mit permethyliertem Cyclodextrin
US20110293537A1 (en) * 2008-11-24 2011-12-01 Giovanni Nicolao Berta formulations with anti-neoplastic activity
CN101757640B (zh) * 2009-06-09 2011-08-31 东华大学 一种鹰嘴豆异黄酮与环糊精包合物的制备
US9925274B2 (en) 2012-11-15 2018-03-27 Sapiotec Gmbh Delphinidin complex as an antiphlogistic or immunosuppressive active ingredient
KR20150107742A (ko) 2012-12-11 2015-09-23 자피오텍 게엠베하 흑색종 세포를 퇴치하기 위한 델피니딘
CN110325217B (zh) 2017-01-09 2023-08-08 塞法姆公司 制备水溶性毛喉萜的新工艺

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3949085A (en) * 1970-05-27 1976-04-06 Chinoin Gyogyszer-Es Vegyeszeti Termakek Gyara Rt Anabolic-weight-gain promoting compositions containing isoflavone derivatives and method using same
JPS5920230A (ja) * 1982-07-19 1984-02-01 チバ−ガイギ−・アクチエンゲゼルシヤフト ピルプロフエン含有薬剤
HU194858B (en) * 1982-12-03 1988-03-28 Chinoin Gyogyszer Es Vegyeszet Process for producing dibenzo/b,d/pirane derivatives and pharmaceutical compositions containing them
EP0129893B1 (en) * 1983-06-28 1991-09-04 Takeda Chemical Industries, Ltd. Ground mixture

Also Published As

Publication number Publication date
CN86106889A (zh) 1987-07-15
KR900000542B1 (ko) 1990-01-31
JPH0688993B2 (ja) 1994-11-09
JPS62103077A (ja) 1987-05-13
SU1757472A3 (ru) 1992-08-23
UA19813A (uk) 1997-12-25
DE3688114D1 (de) 1993-04-29
RU2022970C1 (ru) 1994-11-15
EP0214647B1 (de) 1993-03-24
FI86958C (fi) 1992-11-10
US5043326A (en) 1991-08-27
FI863652A0 (fi) 1986-09-10
HUT41759A (en) 1987-05-28
CA1288424C (en) 1991-09-03
ATE87319T1 (de) 1993-04-15
US4826963A (en) 1989-05-02
DD254939A5 (de) 1988-03-16
CS653586A3 (en) 1992-10-14
PL261349A1 (en) 1987-06-29
FI86958B (fi) 1992-07-31
CS276944B6 (en) 1992-10-14
EP0214647A3 (en) 1987-09-30
KR870002842A (ko) 1987-04-13
HU199444B (en) 1990-02-28
CN1006889B (zh) 1990-02-21
EP0214647A2 (de) 1987-03-18

Similar Documents

Publication Publication Date Title
FI863652A (fi) 7-isopropoxiisflavoninklusionskomplex bildat med cyklodextrin och ett foerfarande foer dess framstaellning.
DE69328192D1 (de) Injizierbare Arzneizubereitungen enthaltend Taxanderivate
IT8821535A0 (it) Derivati 4' fosfato di glucosidi della epipodofillotossina e relative composizioni farmaceutiche.
SE8505112D0 (sv) Novel pharmacological compounds
PT86819A (pt) Process for the preparation of novel insulin derivatives and of pharmaceutical compositions containing the same
IT1201149B (it) Complessi di bioflavonoidi con fosfolipidi,loro preparazione,uso e composizioni farmaceutici e cosmetiche
IT8521602A0 (it) Complessi di flavanolignani con fosfolipidi, loro preparazione e relative composizioni farmaceutiche.
ATE161836T1 (de) 4-substituierte-2-deoxy-2,3-didehydro alpha-d- neuraminsäure antivirale derivate
FI931031A (fi) Mometasonfuroatmonohydrat, foerfarande foer dess framstaellning och farmaceutiska sammansaettningar
IL89840A0 (en) Substituted flavonoid compounds and salts thereof,their preparation and pharmaceutical compositions containing them
ES2130111T3 (es) Derivados de ciclohexano, preparaciones que los contienen y su utilizacion.
KR890700125A (ko) 신규 벤즈이미다졸 유도체, 그 제조방법 및 이 화합물을 함유하는 제약 조성물
MX9203320A (es) Composicion antialergica que contiene compuestos biciclicos switterionicos.
ES2062610T3 (es) Compuesto diarilico anti-ateroesclerotico.
SE8404065D0 (sv) Novel biologically active compounds
FI913034A0 (fi) Foerening med magsyrainhiberande effekt och foerfarande foer dess framstaellning.
SE8600658D0 (sv) Novel composition of matter
IT8867891A0 (it) Derivati terziobutilati di benzilidene canfora procedimento per la loro preparazione,loro impiego come agenti anti ossidanti e composizioni cosmetiche e farmaceutiche che li contengono
MX9203361A (es) Composiciones farmaceuticas que contienen cloruro de galio.
SE8006550L (sv) Farmakologisk komposition, samt sett for dess framstellning
IT8024152A0 (it) Derivati dell'1,1,2-trifenilpropano e dell'1,1,2-trifenilpropene, procedimento per la loro preparazione e composizioni farmaceutiche contenenti i composti
PT86933A (pt) Process for the preparation pf optically active oxo-isoindolinyul derivatives and of pharmaceutical compositions containing the same
ITMI911445A1 (it) Impiego di derivati fosfolipidici per la preparazione di composizioni farmaceutiche aventi attivita' immunosoppressiva
DE3576687D1 (de) Chinatsalze der antimalarischen verbindung mefloquin.

Legal Events

Date Code Title Description
MM Patent lapsed
MM Patent lapsed

Owner name: CHINOIN GYOGYSZER ES VEGYESZETI TERMEKEK GYARA RT.